A Nanoscale Insight into Tumor Immunology: When Failed Experiments Open New Doors Dr. Shiladitya Sengupta, Associate Professor of Medicine at Brigham and Women’s Hospital/Harvard Medical School West Village G 104 April 8, 2025 3:30 pm posted in: CaNCURE Seminar...
Best Practices for Start-up Companies founded with Academic Technology Mark Tepper, President & CSO, Corbus Pharmaceuticals (Feb 20) 123 Snell Library — NEU February 20, 2015 3:30 pm posted in: Joint CaNCURE and Nanomedicine Academy Seminar Development of...
Cancer Nanomedicines: Promises and challenges Vahe Bedian, Director of Oncology External Projects, AstraZeneca Pharmaceuticals 123 Snell Library — NEU March 27, 2015 3:30 pm posted in: Joint CaNCURE and Nanomedicine Academy Seminar The National Nanotechnology...
HPV and Cervical Cancer: Doctor and patient perspectives Christine Baze & Eileen Duffy Lind, Patient Advocates Jimmy Fund 836A/B — DFCI April 8, 2015 5:30 pm posted in: CaNCURE Professional Development Activity Be Prepared for Test Changes – MCAT 2015 Alden...
CaNCURE New Student Orientation Anne L van de Ven, Assistant Director, CaNCURE 425 Shillman Hall — NEU July 10, 2015 12:00 pm posted in: CaNCURE orientation Nanomedicine Day — June 15, 2015 450 Dodge Hall — NEU June 15, 2015 12:00 pm posted...
How to create a research e-portfolio Anne L van de Ven, Assistant Director, CaNCURE 435 Egan — NEU August 7, 2015 4:00 pm posted in: CaNCURE Professional Development Activity Frontiers in cancer immunology Hye-Jung Kim, Ph.D., Instructor of Microbiology and...
